Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Macopharma Nordic Aktiebolag
AB
Active
Org 5565713731
Garnisonsgatan 25 A, 254 66
Helsingborg
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1999
7 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Macopharma Nordic Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
15M
30M
45M
60M
50M
2020
52M
2021
45M
2022
38M
2023
36M
2024
EBITDA
SEK millions
0M
1M
3M
4M
6M
2M
2020
2M
2021
5M
2022
4M
2023
4M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
50 424
52 156
45 497
38 211
36 335
Staff expenses
—
—
—
—
—
EBITDA
1 646
2 403
4 550
3 880
3 953
Depreciation & amort.
−1 184
−1 871
−2 762
−3 532
−3 637
EBIT
462
532
1 788
348
316
Net financials
−324
441
−712
−287
204
Profit before tax
308
974
1 077
61
520
Tax
−0
−0
−0
−0
−0
Net profit
308
974
1 077
61
520
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
26 404
22 918
24 829
20 022
20 154
Equity
12 910
13 883
13 986
14 047
14 567
Long-term debt
6 170
620
4 410
770
0
Short-term debt
7 325
8 415
6 433
5 206
5 588
Total debt
13 495
9 035
10 843
5 976
5 588
Financial ratios
5-year trend
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
2020
2024
Equity ratio
72.3%
This company
38.2%
Market median
+89% vs market
2020
2024
Return on equity
3.6%
This company
18.4%
Market median
-80% vs market
2020
2024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2020
2024
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
2020
2024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Macopharma Nordic Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
